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Human immunodeficiency virus type 1 
(HIV-1) is the causative virus of human 
acquired immunodeficiency syndrome 
(AIDS). Due to the lack of appropriate 
animal models, basic studies on HIV-1 
replication, pathogenesis, and evolu-
tion, have been limited to cellular and 
molecular levels (Nomaguchi et al., 2008). 
Moreover, applied clinical studies in vivo 
also have been forced to use simian immu-
nodeficiency virus isolated from macaques 
(SIVmac) and/or chimeric virus between 
SIVmac and HIV-1 (SHIV) based on our 
pioneering work 20 years ago (Shibata 
et al., 1991; Sakuragi et al., 1992). This 
experimental hindrance is mainly origi-
nated from the extremely narrow host 
range of HIV-1. To overcome the difficulty, 
we and others have made every effort to 
develop and establish suitable virus/ani-
mal systems. Because HIV-1 has adapted 
itself from the ancestral SIVs in Africa to 
replicate in humans in a marvelously strict 
way (Kirchhoff, 2009), the most promising 
one would be the use of macaque-tropic 
HIV-1 and macaques (Ambrose et al., 2007; 
Nomaguchi et al., 2008). As input viruses 
for infection of macaques, simian-tropic 
(st)HIV-1, and macaque-tropic HIV-1 
(HIV-1mt) were designed, generated and 
characterized in vitro (Hatziioannou et al., 
2006; Kamada et al., 2006; Thippeshappa 
et al., 2011) and in vivo (Igarashi et al., 
2007; Hatziioannou et al., 2009; Saito 
et al., 2011; Thippeshappa et al., 2011). 
However, any of these HIV-1 derivatives 
neither replicate similarly robustly with the 
SIVmac standard clone in macaque cells 
nor are pathogenic for macaques so far. 
We, therefore, started improving the proto-
type HIV-1mt clone designated NL-DT5R 
by viral adaptation in macaque cells and 
genome manipulation based on bioinfor-
matics (Figure 1A). NL-DT5R contains a 
21-nucleotide SIVmac Gag-capsid (CA) 
element that lacks cyclophilin A (CypA) 
restriction factors against viruses. In 
fact, the TRIM5 allele of this cell line 
was found to be Mamu 1/Mamu 3 (Doi 
et al., 2010), a genotype that phenotypi-
cally shows a strong resistance to SIVmac 
infection (Lim et al., 2010). A subline of 
the MT-IL2I, after CD4-positive cells had 
been enriched by sorting, was designated 
M1.3S and used for infection experiments 
thereafter. Representative results obtained 
in M1.3S are shown in Figure 1B. Viruses 
of the early generation (from the prototype 
NL-DT5R up to MN4–8S) did not replicate 
at all. However, in cynomolgus HSC-F cells 
that are very sensitive to virus infection, 
MN4–8S replicated better than NL-DT5R, 
NL-DT5RS, and MN4–8. Interestingly, 
MN4Rh-3 acquired replication ability in 
M1.3S cells, and MN4Rh-3V exhibited 
further improved replication potential 
(Figure 1B left). On the other hand, the 
mutational effects of SIVmac accessory 
proteins on viral replication are also read-
ily observed in M1.3S cells (Figure 1B 
right). Generally, these effects cannot be 
easily recognized in the established cell 
lines. As clearly observed in Figure 1B, 
each mutation to knock out the expres-
sion of individual accessory protein has 
greatly affected SIVmac replication. In 
particular, the mutations in vif and vpx 
genes have demonstrated a drastic nega-
tive effect. Therefore, it is quite evident that 
restriction factors against virus replication 
(counteracted by viral accessory proteins) 
are amply present in M1.3S cells.
In conclusion, the M1.3S cell line 
is exquisitely suitable to characterize 
macaque-tropic viruses and to investigate 
anti-viral cellular factors. Although primary 
cells are indispensable for basic studies on 
HIV/SIV that have highly adapted them-
selves to replicate in these cells, M1.3S cells 
can alternatively be used to address impor-
tant issues to understand the biology and 
molecular biology of HIV/SIV.
binding activity of the corresponding 
HIV-1 Gag-CA loop [CypA binding loop 
(−) in Figure 1A] and the entire SIVmac 
vif gene (Kamada et al., 2006). NL-DT5RS 
contains a loop sequence between helices 
6 and 7 (h6/7L in Figure 1A) of SIVmac 
Gag-CA relative to NL-DT5R. MN4–8 car-
ries three adaptive mutations in the pol-
integrase and env-gp120 regions. MN4–8S 
contains the h6/7L of SIVmac Gag-CA and 
three adaptive mutations. MN4Rh-3 has an 
additional mutation in Gag-CA relative to 
MN4–8S. We now have a newest clone 
MN4Rh-3V (CXCR4-tropic), which was 
generated by the introduction of several 
mutations deduced from structural analysis 
into Gag-CA. Because CCR5-tropic viruses 
are thought to be clinically more important 
than CXCR4-tropic viruses, we similarly 
have generated a CCR5-tropic clone des-
ignated MN5Rh-3V.
To achieve our purpose to obtain HIV-
1mt clones potentially pathogenic for 
macaques, as a prerequisite, it is critical to 
have macaque cell lines suitable and easily 
usable to characterize many of the virus 
clones generated. However, macaque cell 
lines that are sensitive to various SIV and 
HIV-1mt clones and maintain the char-
acteristics of natural target cells such as 
peripheral blood mononuclear cells were 
not readily available to us. We therefore 
searched for the appropriate cell lines and 
finally paid attention to the macaque cell 
lines immortalized by Herpesvirus saimiri 
(Akari et al., 1996; Fujita et al., 2003; Doi 
et al., 2010). Of various cynomolgus and 
rhesus macaque cell lines in these reports, 
we were particularly interested in the rhe-
sus MT-IL2I cell line (Doi et al., 2010). 
It is the most refractory cell line among 
those examined by us to infection of 
SIVmac and HIV-1mt clones, but is CD4-
positive, CXCR4-positive, and CCR5-
positive. Therefore, it was predicted that 
this cell line expresses potent   intracellular 
www.frontiersin.org  May 2011  | Volume 2  |  Article 115  |  1
OpiniOn Article
published: 23 May 2011
doi: 10.3389/fmicb.2011.00115Figure 1 | Virological characteristics of HiV-1/SiVmac clones. (A) Proviral 
genome structure of various viruses used for infection of M1.3S. Genomes of 
various HIV-1mt clones generated in our laboratory are schematically illustrated. 
Parental clones HIV-1 NL4-3 (Adachi et al., 1986) and SIVmac MA239N (Doi 
et al., 2010) are shown at the top. Accessory gene-inactivated mutants of 
SIVmac MA239N (circled) were constructed by substituting an internal stop 
codon in the nef gene of MA239 mutants (Shibata et al., 1991) with a Glu codon 
as reported for construction of MA239N (Doi et al., 2010). White and gray areas 
indicate the genomic regions of NL4-3 and MA239N, respectively. An arrow and 
arrowheads indicate the site of the four mutations in gag, pol, and env genes, 
respectively. The dotted region contains additional single-nucleotide mutations 
relative to the other clones. Enlarged Gag-CA region is shown on the right. For 
details, see the text. (B) Replication kinetics of the viruses in M1.3S cells. 
Cell-free viruses were prepared from 293T cells transfected with proviral clones 
indicated, and inoculated into 1 × 106 cells of M1.3S. Viral replication was 
monitored at intervals by reverse transcriptase (RT) activity in the culture 
supernatants. The experiments were done as described previously (Kamada 
et al., 2006; Doi et al., 2010). For infection, 6.3 × 104 and 2.4 × 106 RT units of 
MA239N and HIV-1mt clones (left), respectively, and 5.0 × 104 RT units of 
MA239N clones (right) were used. The representative data in two independent 
experiments are shown. Replication of NL -DT5RS, MN4–8, and MN4–8S was 
not detected as observed for NL -DT5R.
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